#NEJM Group #Clinical Practice #Jiro Health

Jiro Health Partners with NEJM Group for Enhanced Clinical Insights

In a significant development for the medical community, Jiro Health has entered into a multi-year agreement with the NEJM Group, the publisher behind the esteemed New England Journal of Medicine. This strategic partnership aims to seamlessly blend extensive peer-reviewed research from NEJM publications with Jiro’s innovative Practice Intelligence platform. The result? A smart solution that enhances clinical practice by ensuring that clinicians have easy access to the most relevant evidence-based information in real-time.

Connecting Evidence to Practice

As the landscape of medical literature expands annually, physicians often face the overwhelming challenge of sifting through vast information to discern what truly impacts their patients’ care. Accessing data isn’t the main issue; rather, it’s the ability to pinpoint critical findings that align with the specific circumstances of each patient. Jiro’s mission is to remedy this by transforming real-world practice intelligence into actionable insights.

According to Greg Field, Co-Founder and CEO of Jiro, “The right evidence exists for almost every clinical decision. What’s been missing is a way to connect it to the right clinician before the moment passes.” By merging NEJM Group’s content with Jiro’s unique insights, clinicians can now receive personalized research recommendations directly related to their specialties and patient demographics.

Enhanced Features

The Jiro platform continuously updates users on clinical, operational, and financial performance, now enriched further thanks to content from NEJM Group. Two main features stand out:

1. Discover: This feature automatically curates relevant journal articles, clinical trials, and expert commentaries, prompting clinicians with vital information as their practice evolves.
- For instance, if a rheumatologist begins treating patients with a newly-approved drug, the Discover feature highlights pertinent studies and safety data, presenting them with knowledge even before they think to search.

2. Consult: This component combines published research with real-world patient data, providing context to complex clinical dilemmas. As an example, it can aid clinicians in evaluating whether to continue a specific treatment for a patient with a complicated medical history by cross-referencing relevant literature with their patient’s data.

Dr. Geeta Nayyar, MD and Chief Medical Officer at Jiro, passionately shared her perspective: “As a practicing physician, I know what it feels like to search for evidence that should already be in front of me. What Jiro and NEJM have created is unlike any other tool; the key literature is available because Jiro understands my practice, not simply because I remembered to look for it.”

Commitment to Quality

The partnership with NEJM Group underlines Jiro's commitment to delivering trustworthy, peer-reviewed educational content to healthcare providers. As David Sampson, NEJM Group's Vice President and Chief Publishing Officer, emphasized,